课题基金 / 基金详情

Examination of drugs effective for Ieishmaniasis

Examination of drugs effective for Ieishmaniasis
检查对利什曼病有效的药物
批准号:
07557209
负责人:
HASHIGUCHI Yoshihisa
金额:
$4.35万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997

项目摘要

项目成果

HASHIGUCHI Yoshihisa的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In leishmaniasis, antimonials such as Glucantime and Pentostum are the first choice of treatment for a wide range of clinical forms of the disease in the world. However , these drugs have several disadvatages including severe side effects when they are administered intramuscularly or intravenously to the patients. Therefore, it is necessary to develop urgently more effective and cost-efficient drugs for the treatment.In this study, we tried to search for some drugs, which are non-side effective and easy handling even in rural areas without any sophisticated equipments. Based on our field trial with swveral drugs, it was found that both of the paromomycin ointment and the lotion of Glucnatime mixed with mercury chrome were highly effective for cutaneous lesions caused by Leishmania (Viannia) panamensis and L.(V.) guyanensis. On the other hand, antimalarial drugs, mefloquine and artesunate, were used as oral therapy for cutaneous leismaniasis. These drugs gave a satisfactory result for patients caused by the two species mentioned above, L.(V.) panamensis and L.(V.) guyanensis. In order to get some information on the action machanisms of the drugs in patients treated. skin blopsy materisls were examined electron-microscopically.For diagnosis of patient and/or evaluation of drug effectiveness, PS-PCR (polymorphism specific-polymerase chain reaction) and PCR tergeting mini-exone gene were also developed in addition to AP-PCR.An in vitro experimental model using Lamdr2 gene was established to study mechanisms of drug-resistance at molecular level. In animals infected with Leishmania, an anti-tumor drug, ONO4007 was tested. The results obtained suggested that the drug would be useful for leishmaniasis treatment, when it was used in combination with other anti-leishmanial drugs, such as antimonials, mefloquine and artesunate.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
橋口義久: "世界の感染症アフリカトリパノソーマ症,オンコセルカ症,シャーガス症,バベシア症,リーシュマニア症,リンパ管フィラリア症" 菜根出版, (1997)
Yoshihisa Hashiguchi:“世界传染病非洲锥虫病、盘尾丝虫病、恰加斯病、巴贝虫病、利什曼病、淋巴丝虫病”Nane Publishing,(1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Hashiguchi: "Estudios sobre la Leishmaniasis en el Nuevo Mundo y su Transmision con Especial Referencia al Ecuador" Kyowa Printing Co., 147 (1996)
Y.Hashiguchi:“Estudios sobre la Leishmaniasis en el Nuevo Mundo y su Transmission con Especial Referencia al Ecuador”Kyowa Printing Co.,147 (1996)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
37
    Studies on the transmission and pathobiology of New and Old World leishmaniases
    • 批准号:
      18256004
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $27.21万
    • 财政年份:
      2006
    • 负责人:
      HASHIGUCHI Yoshihisa
    • 依托单位:
    Pathophysiological studies on the New and Old World leishmaniases and their transmission
    • 批准号:
      14256002
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $24.63万
    • 财政年份:
      2002
    • 负责人:
      HASHIGUCHI Yoshihisa
    • 依托单位:
    Studies on leishmaniasis and its transmission in Central and South Americas
    • 批准号:
      10041199
    • 项目类别:
      Grant-in-Aid for Scientific Research (A).
    • 资助金额:
      $15.55万
    • 财政年份:
      1998
    • 负责人:
      HASHIGUCHI Yoshihisa
    • 依托单位:
    Studies on New World leishmaniasis and its transmission
    • 批准号:
      08041177
    • 项目类别:
      Grant-in-Aid for international Scientific Research
    • 资助金额:
      $9.79万
    • 财政年份:
      1996
    • 负责人:
      HASHIGUCHI Yoshihisa
    • 依托单位: